Thomas Elter
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 43
- Chronic Lymphocytic Leukemia Research 36
- Glioma Diagnosis and Treatment 7
-
- Lymphoma Diagnosis and Treatment 26
- Co-authors
- Andreas Engert (17 shared papers)Michael Hallek (38 shared papers)Joyce I. Boye (1 shared paper)Freerk T. Baumann (14 shared papers)Wilhelm Bloch (15 shared papers)Nicole Skoetz (4 shared papers)Fiona Streckmann (6 shared papers)Clemens‐Martin Wendtner (13 shared papers)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (10 papers)Cochrane Database of Systematic Reviews (4 papers)Haematologica (3 papers)Supportive Care in Cancer (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Elter
66 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 101
- Genetics 1.1k
- Pathology and Forensic Medicine 1.1k
- Hematology 397
- Oncology 820
- Immunology 487
Countries citing papers authored by Thomas Elter
This map shows the geographic impact of Thomas Elter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Elter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Elter more than expected).
Fields of papers citing papers by Thomas Elter
This network shows the impact of papers produced by Thomas Elter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Elter. The network helps show where Thomas Elter may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Elter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 271 | |
| 2 | 2003 | 225 | |
| 3 | 2014 | 182 | |
| 4 | 2005 | 153 | |
| 5 | 2014 | 135 | |
| 6 | 2016 | 115 | |
| 7 | 2007 | 107 | |
| 8 | 2011 | 99 | |
| 9 | 2019 | 78 | |
| 10 | 2012 | 76 | |
| 11 | 2018 | 71 | |
| 12 | 2013 | 65 | |
| 13 | 2011 | 64 | |
| 14 | 2009 | 57 | |
| 15 | 2014 | 56 | |
| 16 | 2012 | 44 | |
| 17 | 2006 | 43 | |
| 18 | 2006 | 39 | |
| 19 | 2001 | 38 | |
| 20 | 2014 | 38 |
About Thomas Elter
Thomas Elter is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Immunology and Public Health, Environmental and Occupational Health, having authored 68 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (26 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Acute Lymphoblastic Leukemia research (14 papers), Cancer survivorship and care (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers), Lymphatic System and Diseases (7 papers) and Glioma Diagnosis and Treatment (7 papers). The work is most often cited by research in Genetics (1.1k citations), Pathology and Forensic Medicine (1.1k citations), Hematology (397 citations), Oncology (820 citations) and Immunology (487 citations). Thomas Elter has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas Engert, Michael Hallek, Joyce I. Boye, Freerk T. Baumann, Wilhelm Bloch, Nicole Skoetz, Fiona Streckmann, Clemens‐Martin Wendtner, Ina Monsef and Alexander Schenk. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cochrane Database of Systematic Reviews, Haematologica and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.